Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer

Abstract Metastasis is one of the leading causes of cancer-related death worldwide. Fascin, a protein that bundles actin filaments to produce protrusions in cancer cells, plays a significant role in the enhancement of cell migration. This protein has been shown that the overexpression of this protei...

Full description

Saved in:
Bibliographic Details
Main Authors: Alejandro Rodríguez-Martínez, Lucía Giraldo-Ruiz, María C. Ramos, Irene Luque, Diogo Ribeiro, Fátima Postigo-Corrales, Begoña Alburquerque-González, Silvia Montoro-García, Ana Belén Arroyo-Rodríguez, Pablo Conesa-Zamora, Ana María Hurtado, Ginés Luengo-Gil, Horacio Pérez-Sánchez
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-96457-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850204039977893888
author Alejandro Rodríguez-Martínez
Lucía Giraldo-Ruiz
María C. Ramos
Irene Luque
Diogo Ribeiro
Fátima Postigo-Corrales
Begoña Alburquerque-González
Silvia Montoro-García
Ana Belén Arroyo-Rodríguez
Pablo Conesa-Zamora
Ana María Hurtado
Ginés Luengo-Gil
Horacio Pérez-Sánchez
author_facet Alejandro Rodríguez-Martínez
Lucía Giraldo-Ruiz
María C. Ramos
Irene Luque
Diogo Ribeiro
Fátima Postigo-Corrales
Begoña Alburquerque-González
Silvia Montoro-García
Ana Belén Arroyo-Rodríguez
Pablo Conesa-Zamora
Ana María Hurtado
Ginés Luengo-Gil
Horacio Pérez-Sánchez
author_sort Alejandro Rodríguez-Martínez
collection DOAJ
description Abstract Metastasis is one of the leading causes of cancer-related death worldwide. Fascin, a protein that bundles actin filaments to produce protrusions in cancer cells, plays a significant role in the enhancement of cell migration. This protein has been shown that the overexpression of this protein is related to the appearance of different types of cancer, such as colorectal cancer. In this study, we conducted in silico screening of the Enamine library, a compound library with a broad chemical space. Using a ligand-based virtual screening approach based on the pharmacophore model of G2, we identified the predicted inhibitors. First, these compounds were validated by physicochemical analysis. Differential scanning calorimetry (DSF) was used to study the binding between the predicted compounds and fascin protein, followed by an F-actin bundling assay to determine which compounds inhibited the bundling function of fascin. Z1362873773, which exhibited binding to fascin and inhibited F-actin bundling, was further tested in cell cultures to assess its effects on cancer cell viability and migration as well as in organoid models to evaluate potential cytotoxicity. Finally, we established a protocol that can be applied to discover anti-fascin agents from diverse compound libraries. A new molecule has been identified with considerable fascin inhibitory and migration-arresting capacity, which may lead to the development of new therapies to treat cancer.
format Article
id doaj-art-fcd76cd0e8e943c08294ce98348de656
institution OA Journals
issn 2045-2322
language English
publishDate 2025-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-fcd76cd0e8e943c08294ce98348de6562025-08-20T02:11:22ZengNature PortfolioScientific Reports2045-23222025-04-0115111510.1038/s41598-025-96457-xDiscovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancerAlejandro Rodríguez-Martínez0Lucía Giraldo-Ruiz1María C. Ramos2Irene Luque3Diogo Ribeiro4Fátima Postigo-Corrales5Begoña Alburquerque-González6Silvia Montoro-García7Ana Belén Arroyo-Rodríguez8Pablo Conesa-Zamora9Ana María Hurtado10Ginés Luengo-Gil11Horacio Pérez-Sánchez12Structural Bioinformatics and High Performance Computing Research Group (BIO-HPC), UCAM Universidad Católica de Murcia (UCAM)Departamento de Química Física, Instituto de Biotecnología y Unidad de Excelencia de Química aplicada a Biomedicina y Medioambiente, Universidad de GranadaFundación MEDINA, PTS Health Sciences Technology ParkDepartamento de Química Física, Instituto de Biotecnología y Unidad de Excelencia de Química aplicada a Biomedicina y Medioambiente, Universidad de GranadaGenetics, Molecular Pathology and Rare Diseases Research Group, Universidad Católica de Murcia (UCAM)Genetics, Molecular Pathology and Rare Diseases Research Group, Universidad Católica de Murcia (UCAM)Genetics, Molecular Pathology and Rare Diseases Research Group, Universidad Católica de Murcia (UCAM)Genetics, Molecular Pathology and Rare Diseases Research Group, Universidad Católica de Murcia (UCAM)Molecular Pathology and Pharmacogenetics Research Group, Instituto Murciano de Investigación Biosanitaria (IMIB), Hospital General Universitario Santa LucíaGenetics, Molecular Pathology and Rare Diseases Research Group, Universidad Católica de Murcia (UCAM)Genetics, Molecular Pathology and Rare Diseases Research Group, Universidad Católica de Murcia (UCAM)Genetics, Molecular Pathology and Rare Diseases Research Group, Universidad Católica de Murcia (UCAM)Structural Bioinformatics and High Performance Computing Research Group (BIO-HPC), UCAM Universidad Católica de Murcia (UCAM)Abstract Metastasis is one of the leading causes of cancer-related death worldwide. Fascin, a protein that bundles actin filaments to produce protrusions in cancer cells, plays a significant role in the enhancement of cell migration. This protein has been shown that the overexpression of this protein is related to the appearance of different types of cancer, such as colorectal cancer. In this study, we conducted in silico screening of the Enamine library, a compound library with a broad chemical space. Using a ligand-based virtual screening approach based on the pharmacophore model of G2, we identified the predicted inhibitors. First, these compounds were validated by physicochemical analysis. Differential scanning calorimetry (DSF) was used to study the binding between the predicted compounds and fascin protein, followed by an F-actin bundling assay to determine which compounds inhibited the bundling function of fascin. Z1362873773, which exhibited binding to fascin and inhibited F-actin bundling, was further tested in cell cultures to assess its effects on cancer cell viability and migration as well as in organoid models to evaluate potential cytotoxicity. Finally, we established a protocol that can be applied to discover anti-fascin agents from diverse compound libraries. A new molecule has been identified with considerable fascin inhibitory and migration-arresting capacity, which may lead to the development of new therapies to treat cancer.https://doi.org/10.1038/s41598-025-96457-x
spellingShingle Alejandro Rodríguez-Martínez
Lucía Giraldo-Ruiz
María C. Ramos
Irene Luque
Diogo Ribeiro
Fátima Postigo-Corrales
Begoña Alburquerque-González
Silvia Montoro-García
Ana Belén Arroyo-Rodríguez
Pablo Conesa-Zamora
Ana María Hurtado
Ginés Luengo-Gil
Horacio Pérez-Sánchez
Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer
Scientific Reports
title Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer
title_full Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer
title_fullStr Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer
title_full_unstemmed Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer
title_short Discovery of Z1362873773: a novel fascin inhibitor from a large chemical library for colorectal cancer
title_sort discovery of z1362873773 a novel fascin inhibitor from a large chemical library for colorectal cancer
url https://doi.org/10.1038/s41598-025-96457-x
work_keys_str_mv AT alejandrorodriguezmartinez discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT luciagiraldoruiz discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT mariacramos discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT ireneluque discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT diogoribeiro discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT fatimapostigocorrales discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT begonaalburquerquegonzalez discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT silviamontorogarcia discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT anabelenarroyorodriguez discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT pabloconesazamora discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT anamariahurtado discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT ginesluengogil discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer
AT horacioperezsanchez discoveryofz1362873773anovelfascininhibitorfromalargechemicallibraryforcolorectalcancer